Article Text

Download PDFPDF
Statin therapy and gastric cancer death
  1. Shih-Wei Lai1,2,
  2. Yu-Hung Kuo3,
  3. Kuan-Fu Liao4,5
  1. 1College of Medicine, China Medical University, Taichung, Taiwan
  2. 2Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan
  3. 3Department of Research, Taichung Tzu Chi Hospital, Taichung, Taiwan
  4. 4College of Medicine, Tzu Chi University, Hualien, Taiwan
  5. 5Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan
  1. Correspondence to Dr Kuan-Fu Liao; kuanfuliaog{at}gmail.com

Statistics from Altmetric.com

Statins are commonly used for the treatment of hypercholesterolaemia. The association between statin use and gastric cancer risk has been extensively assessed.1 2 Recently, a cohort study in UK conducted by Spence et al revealed that statin use after a diagnosis of gastric cancer was associated with a lower hazard of cancer-specific death (HR=0.83, 95% CI 0.74 to 0.93).3 This result was partially compatible with that of a cohort study in Republic of Korea showing that statin use for more than 6 months was associated with increased survival rate of gastric cancer compared with non-use (HR=0.168, 95% CI 0.032 to 0.881).4 In order to test the …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.